chrX-84164381-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014496.5(RPS6KA6):āc.88G>Cā(p.Gly30Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,184,385 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014496.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPS6KA6 | NM_014496.5 | c.88G>C | p.Gly30Arg | missense_variant | 2/22 | ENST00000262752.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RPS6KA6 | ENST00000262752.5 | c.88G>C | p.Gly30Arg | missense_variant | 2/22 | 1 | NM_014496.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000896 AC: 1AN: 111604Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33804
GnomAD3 exomes AF: 0.0000115 AC: 2AN: 173965Hom.: 0 AF XY: 0.0000169 AC XY: 1AN XY: 59233
GnomAD4 exome AF: 0.0000196 AC: 21AN: 1072781Hom.: 0 Cov.: 25 AF XY: 0.0000205 AC XY: 7AN XY: 340919
GnomAD4 genome AF: 0.00000896 AC: 1AN: 111604Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33804
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2021 | The c.88G>C (p.G30R) alteration is located in exon 2 (coding exon 2) of the RPS6KA6 gene. This alteration results from a G to C substitution at nucleotide position 88, causing the glycine (G) at amino acid position 30 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at